| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Adam Stuart Nelson |
Development of Viral Specific T cells (VSTs) to treat HPV-driven squamous cell carcinoma in patients with FA |
Fanconi Anemia Research Fund |
FARF 2019 Nelson |
11/15/2019 - 11/14/2020 |
$10,000 |
| Kasiani C Myers, MD |
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine |
Children's Hospital Boston (National Institutes of Health) |
GENFD0001792995 |
09/15/2019 - 06/30/2020 |
$14,849 |
| Parinda Mehta, MD |
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients with Fanconi Anemia |
Food and Drug Administration |
R01FD006353 |
09/01/2019 - 06/30/2020 |
$435,489 |
| Parinda Mehta, MD |
Quercetin Chemoprevention for Squamous Cell Carinoma in Patients with Fanconi Anemia |
Gateway for Cancer Research |
G18500 |
10/01/2019 - 09/30/2020 |
$266,666 |
| Pooja Khandelwal, MD |
Open-Label, Single-Arm, Multicenter Study, of Combination anti-CD3/CD7 Immunotoxin (T-Guard) for Steroid-Refractory Acute Graft-versus-Host Disease BMT CTN Protocol #1802 |
National Marrow Donor Program (National Institutes of Health) |
1802 |
11/01/2019 - 10/31/2022 |
$25,803 |
| Rebecca A Marsh, MD |
A randomized trial of low versus moderate exposure busulfan for infants with severe combined immunodeficiency (SCID) receiving TCRαβ+/CD19+ depleted transplantation: A Phase II study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC) PIDTC “CSIDE” |
Children's Hospital Los Angeles (National Institutes of Health) |
NMD 1801 |
04/01/2019 - 03/31/2022 |
$10,483 |
| Sonata Jodele, MD |
Thrombotic microangiopathy (TMA) associated MODS after stem celltransplantation |
National Institutes of Health (NIH) |
R01HD093773 |
09/01/2019 - 08/31/2020 |
$680,349 |
| Stella M Davies, MD |
Vitamin A to Improve Gut Permeability and Reduce Infection and GVHD in Children Receiving Stem Cell Transplant |
Gateway for Cancer Research |
G17300 |
07/01/2019 - 06/30/2020 |
$126,595 |
| Stella M Davies, MD |
Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia |
Northwestern University Medical School (National Institutes of Health) |
60052734 CCHMC |
04/01/2019 - 01/31/2021 |
$44,498 |
| Stella M Davies, MD |
Childhood Cancer Survivor Study |
St Jude's Children's Hospital (National Institutes of Health) |
U24CA055727 |
12/01/2019 - 11/30/2020 |
$152,706 |
| Current Year Direct |
$1,767,438 |
